HPV Urine Test FAQs
Product Information
持續感染可引致子宮頸癌、外陰癌、陰道癌、陰莖癌等
HPV 6、11 可引致 9 成的生殖器疣俗稱椰菜花，一般出現在陰莖的包皮系帶、陰莖冠溝、尿道出口、肛門、陰道出口、陰唇、陰道及子宮頸；其餘低風險 HPV 同屬 2A 及 2B 類致癌物
Clinical comparison with HPV cervical / penile swab test results demonstrates the accuracy of INDICAID HPV Urine test has an overall agreement of 98.9%
INDICAID™ HPV Urine Test and Pap smear test are two different technologies.
INDICAID™ HPV Urine Test detects the HPV virus DNA from users’ urine sample; whereas Pap smear test detects precancerous lesion through examination on the collected cervical cells under a microscope performed by laboratory technicians.
篩查的次序可以由 HPV DNA 檢測開始，如檢測出 HPV 病毒，可以再透過柏氏抺片檢查已知的病毒是否出現細胞病變。
INDICAID™ HPV Urine Test is designed to detect HPV virus DNA from urine sample rather than mouth, throat or other areas. Should you wish to test for HPV from other areas, please seek professional medical advice.
Test Eligibility
Regular HPV tests are recommended for the following groups that are prone to higher risk of HPV infection, including: early first sexual intercourse, multiple sexual partners, active sex life, unsafe life, regular smokers, chronic immunosuppression, use of contraceptive pills, pregnant / postpartum women5.
It is suitable for both men and women. It is reported that 80% of men and women will acquire HPV in their lifetime, everyone can transmit HPV to their partners. Therefore, it is recommended to get tested for HPV regularly to protect yourself and your partner6。
部分市場上的 HPV 測試產品要求自行於陰道內採樣，因此只適合女士使用。INDICAID™妥析™ HPV 尿液樣本測試是透過尿液樣本來檢測用家是否存有 HPV DNA，因此沒有性別限制，男女同時適用。
Women should avoid collecting urine sample for the test during menstruation as excessive impurities might affect test result.
Yes, pregnant women can use the test.
Yes, all users must be aged 18 or above.
不論任何國籍，只要能提供香港郵寄地址以便收取產品及香港手提電話號碼作驗證，任何國籍的人士均可進行測試。
No. The test is only applicable to humans at the moment.
How to Use
Activate your kit online
- 掃描您的專屬二維碼
- 填寫線上表格
- Choose your sample submission method
- 採集排尿的首段 90-100亳升尿液樣本於採樣瓶內
- 將保存液倒入已載有尿液的採樣瓶中
- Re-cap tightly the filled urine collection bottle. Gently invert 3-5 times to mix the urine with the preservative
- 填寫樣本標貼並張貼在已裝滿尿液的採樣瓶上
- 將採樣瓶放入樣本袋中並將其密封
- 將封好的樣本袋放入外包裝袋中並將其密封
- 必須於採樣後24小時內根據已選擇的樣本遞交方式遞交樣本
No, you can maintain normal sex life before the test.
Yes, but please avoid drinking excessive fluid prior to urine collection.
You should store the sample between 15-30°C and avoid sunlight.
Pack & return your sample
After scanning your unique QR code, you can choose your sample submission method via the online form, including sample pick-up ($120) / drop-off.
Please ensure your urine sample is returned and packed correctly, otherwise your submitted sample will not be processed and no refund will be granted:
您可以於採樣後 24 小時內遞交樣本至以下地點：
*請注意，遞交樣本時需要開啟確認短訊上的連結，並掃描樣本收集箱上的二維碼以確認遞交日期和時間。
Pick-up service is currently unavailable for remote areas. You can choose to drop off your sample to our drop-off points.
Should you wish to change your arrangement for sample pick-up, please contact our customer service at 3700 8888.
Receive Report
Test report will be available via email & SMS
電子化驗報告將於樣本送達化驗所後5個工作天內以手機短訊及電郵發出。
Your sample will be processed at the PHASE LAB.
What's Next?
如檢測出HPV 病毒陽性，請向醫生尋求後續跟進。 我們亦會主動與您聯絡提供協助。
Routine HPV screening tests for cervical cancer should be done. If you experience any swelling, bleeding, pain or other discomfort, seek medical advice promptly.
Please contact our customer service at 3700 8888 for a receipt.
References
- Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. CO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023.
- Marx, V. Method of the year: long-read sequencing. Nat Methods 20, 6–11 (2023).
- Centre for Health Protection: Health Topics on Cervical Cancer (2023).
- Department of Health: DH introduces human papillomavirus testing and calls on public to undergo regular cervical cancer screening (2023).
- Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020 Jul;40(5):602-608. doi: 10.1080/01443615.2019.1634030. Epub 2019 Sep 10. Erratum in: J Obstet Gynaecol. 2020 May;40(4):590. PMID: 31500479; PMCID: PMC7062568.
- International Agency for Research on Cancer: IARC Monographs on the Identification of Carcinogenic Hazards to Humans (2023).
- The Family Planning Association of Hong Kong: Health Info on Sexually Transmissible Diseases. Accessed on 30th June 2023.
- Human papillomavirus vaccines: WHO position paper, December 2022. WHO REFERENCE NUMBER: WER No 50, 2022, 97, 645–672
- Chesson, Harrell W. PhD; Dunne, Eileen F. MD, MPH; Hariri, Susan PhD; Markowitz, Lauri E. MD. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sexually Transmitted Diseases 41(11):p 660-664, November 2014.
- Scientific Committee on Vaccine Preventable Diseases and Scientific Committee on AIDS and STI, Centre for Health Protection: Consensus Statement on the use of Human Papillomavirus (HPV) Vaccine in prevention of cervical cancer (2016).
- Cancer Expert Working Group on Cancer Prevention and Screening (CEWG), Centre for Health Protection: Recommendations on Prevention and Screening for Cervical Cancer For Health Professionals (2021).